Abstract:BACKGROUND: Sleeve gastrectomy (SG) can induce prominent remission of type 2 diabetes mellitus. However, the long-term remission rate of diabetes usually decreases over time. Oligofructose has been verified to modulate host metabolism. The aim of this study was to explore the protective effect of oligofructose on high-fat diet (HFD)-induced metabolic dysfunction after SG.AIM: To study the effect and mechanism of oligofructose on diabetic remission in diabetic rats after SG.METHODS: SG and SHAM operation were performed on diabetes rats induced with an HFD, nicotinamide, and low-dose streptozotocin. Then the rats in the SHAM and SG groups were continuously provided with the HFD, and the rats in sleeve gastrectomy-oligofructose group were provided with a specific HFD containing 10% oligofructose. Body weight, calorie intake, oral glucose tolerance test, homeostasis model assessment of insulin resistance, lipid profile, serum insulin, glucagon-like peptide 1 (GLP-1), total bile acids, lipopolysaccharide (LPS), and colonic microbiota levels were determined and compared at the designated time points. All statistical analyses were performed using Statistic Package for Social Science version 19.0 (IBM, United States), and the statistically significant difference was considered at P < 0.05.RESULTS: At 2 wk after surgery, rats that underwent SG exhibited improved indexes of glucose and lipid metabolism. Compared with the SG group, the rats from SG-oligofructose group exhibited better parameters of glucose and lipid metabolism, lower body weight (526.86 ± 21.51 vs 469.25 ± 21.84, P < 0.001), calorie intake (152.14 ± 9.48 vs 129.63 ± 8.99, P < 0.001), homeostasis model assessment of insulin resistance (4.32 ± 0.57 vs 3.46 ± 0.52, P < 0.05), and LPS levels (0.19 ± 0.01 vs 0.16 ± 0.01, P < 0.05), and higher levels of insulin (1.17 ± 0.17 vs 1.58 ± 0.16, P < 0.001) and GLP-1 (12.39 ± 1.67 vs 14.94 ± 1.86, P < 0.001), and relative abundances of Bifidobacterium (0.0034 ± 0.0014 vs 0.0343 ± 0.0064, P < 0.001), Lactobacillus (0.0161 ± 0.0037 vs 0.0357 ± 0.0047, P < 0.001), and Akkermansia muciniphila (0.0050 ± 0.0024 vs 0.0507 ± 0.0100, P < 0.001) at the end of the study. However, no difference in total bile acids levels was observed between the two groups.CONCLUSION: Oligofructose partially prevents HFD-induced glucose and lipid metabolism damage after SG, which may be due to the changes of calorie intake, insulin, GLP-1, LPS, and the gut microbiota in rats.

Effect of Roux-en-Y Anastomosis on Glucose and LipidMetabolism in Patients with Gastric Carcinoma and Type 2 Diabetes Mellitus

Effect of Different Alimentary Reconstruction for Gastrectomy on the Glu_cose Metabolism in Patients Complicated with Type 2 Diabetes

Comparison of Different Gastric Bypass Procedures in Gastric Carcinoma Patients with Type 2 Diabetes Mellitus.

Retrospective study of the influence of alimentary tract reconstruction after gastrectomy on the blood glucose level in patients with gastric cancers combined with type 2 diabetes mellitus

Relationship Between the Preoperative Body Mass Index and the Improvement of Glycolipid Metabolism in Chinese Type 2 Diabetic Patients after Roux-en-Y Gastric Bypass.

Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus

The Effect of Dyslipidemia on Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus

Retrospective study of the effect of alimentary tract reconstruction after gastrectomy on the treatment of type 2 diabetes mellitus

[Effects of Preoperative Oral Carbohydrate on Postoperative Insulin Resistance in Radical Gastrectomy Patients].

Effect of Roux-en-Y Gastric Bypass Surgery on Hepatic Glucolipid Metabolism in Rats with Obesity Combined with Type 2 Diabetes Mellitus

Blood Glucose Analysis of Patients Combined with Gastric Cancer and Type 2 Diabetes Mellitus Undergoing Distal Gastrectomy with Different Kinds of Gastrointestinal Reconstruction

Combined surgical treatment of gallbladder stones with concomitant type 2 diabetes mellitus: a report of 55 cases

Clinical experience on gastrointestinal metabolic surgery for treatment of obesity combined with type 2 diabetes mellitus

Effectiveness and Safety of Laparoscopic Roux-en-Y Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus

Effect of oligofructose on resistance to postoperative high-fat diet-induced damage of metabolism in diabetic rats after sleeve gastrectomy

Short-term Glucose Metabolism and Gut Hormone Modulations after Billroth II Gastrojejunostomy in Nonobese Gastric Cancer Patients with Type 2 Diabetes Mellitus, Impaired Glucose Tolerance and Normal Glucose Tolerance

Larporoscopic Roux-en-Y Gastric Bypass by Different Anastomoses for the Treatment of Type 2 Diabetes Mellitus

Curative effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus and correlation analysis

Efficacy of laparoscopic gastric bypass vs laparoscopic sleeve gastrectomy in treating obesity combined with type-2 diabetes

An analysis of islet function in patients with type 2 diabetes mellitus after laparoscopic Roux-en-Y gastric bypass surgery

Comparative study on weight loss and remission of metabolic disorders after laparoscopic Roux-en-Y gastric by-pass versus laparoscopic sleeve gastrectomy